European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 147, Issue 1 , Pages 78-82 , November 2009

Age-specific differences in the treatment of cervical cancer in the east and the south of The Netherlands 1989–2004

  • Maaike A. van der Aa

      Affiliations

    • Comprehensive Cancer Centre North East, Enschede/Groningen, The Netherlands
    • Corresponding Author InformationCorresponding author at: Comprehensive Cancer Centre North East, PO Box 330, 9700 AH Groningen, The Netherlands. Tel.: +31 88 2345500; fax: +31 88 2345599.
    • ,
  • Sabine Siesling

      Affiliations

    • Comprehensive Cancer Centre North East, Enschede/Groningen, The Netherlands
    • ,
  • Lonneke V. v.d. Poll-Franse

      Affiliations

    • Eindhoven Cancer Registry, Comprehensive Cancer Centre South, Eindhoven, The Netherlands
    • ,
  • Eltjo M. Schutter

      Affiliations

    • Medisch Spectrum Twente, Department of Gynaecology, Enschede, The Netherlands
    • ,
  • Marnix L. Lybeert

      Affiliations

    • Catharina Hospital, Department of Radiotherapy, Eindhoven, The Netherlands
    • ,
  • Jan Willem W. Coebergh

      Affiliations

    • Eindhoven Cancer Registry, Comprehensive Cancer Centre South, Eindhoven, The Netherlands
    • Erasmus University Medical Centre, Department of Public Health, Rotterdam, The Netherlands

Received 2 September 2008 ,Revised 7 May 2009 ,Accepted 22 July 2009.

References 

  1. Yamashita H, Nakagawa K, Tago M, et al. Comparison between conventional surgery and radiotherapy for FIGO stage I–II cervical carcinoma: a retrospective Japanese study. Gynecol Oncol. 2005;97:834–839
  2. van der Velden J, Samlal R, Schilthuis MS, Gonzalez DG, ten Kate FJ, Lammes FB. A limited role for adjuvant radiotherapy after the Wertheim/Okabayashi radical hysterectomy for cervical cancer confined to the cervix. Gynecol Oncol. 1999;75:233–237
  3. Trimbos JB. Gynaecologische Oncologieklapper. 2nd ed.. Leiden, The Netherlands: Working Group for Gynecological Oncology; 1995;
  4. Work Group Oncologic Gynaecology. www.oncoline.nl.
  5. Ryu HS, Chun M, Chang KH, Chang HJ, Lee JP. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients. Gynecol Oncol. 2005;96:490–495
  6. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144–1153
  7. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340:1137–1143
  8. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999;17:1339–1348
  9. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340:1154–1161
  10. Peters WA, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606–1613
  11. van der Zee J, Gonzalez GD. The Dutch Deep Hyperthermia Trial: results in cervical cancer. Int J Hyperthermia. 2002;18:1–12
  12. Hanselaar AG. Criteria for organized cervical screening programs special emphasis on The Netherlands program. Acta Cytol. 2002;46:619–629
  13. Ederer F, Heise H. Instructions to IBM 6500 programmers in processing survival computations. Methodological note no. 10, End Results Evaluation Section. Bethesda MD: National Cancer Institute; 1959.
  14. Abayomi J, Kirwan J, Hackett A, Bagnall G. A study to investigate women's experiences of radiation enteritis following radiotherapy for cervical cancer. J Hum Nutr Diet. 2005;18:353–363
  15. Hawighorst-Knapstein S, Fusshoeller C, Franz C, et al. The impact of treatment for genital cancer on quality of life and body image—results of a prospective longitudinal 10-year study. Gynecol Oncol. 2004;94:398–403
  16. Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D. Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2003;56:937–949
  17. Schouten LJ, Langendijk JA, Jager JJ, van den Brandt PA. Validity of the stage of lung cancer in records of the Maastricht cancer registry, The Netherlands. Lung Cancer. 1997;17:115–122
  18. Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001;358:781–786
  19. Goodheart M, Jacobson G, Smith BJ, Zhou L. Chemoradiation for invasive cervical cancer in elderly patients: outcomes and morbidity. Int J Gynecol Cancer. 2007;
  20. Wright JD, Gibb RK, Geevarghese S, et al. Cervical carcinoma in the elderly: an analysis of patterns of care and outcome. Cancer. 2005;103:85–91
  21. Yellen SB, Cella DF, Leslie WT. Age and clinical decision making in oncology patients. J Natl Cancer Inst. 1994;86:1766–1770
  22. Newcomb PA, Carbone PP. Cancer treatment and age: patient perspectives. J Natl Cancer Inst. 1993;85:1580–1584
  23. Signaleringscommissie Kanker van KWF Kankerbestrijding. Kanker in Nederland; Trends, prognoses en implicaties voor zorgvraag. Oisterwijk: Drukkerij van den Boogaard; 2004.

PII: S0301-2115(09)00471-0

doi: 10.1016/j.ejogrb.2009.07.006

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 147, Issue 1 , Pages 78-82 , November 2009

Article Tools